241 related articles for article (PubMed ID: 29875134)
1. NF-κB-Dependent Lymphoid Enhancer Co-option Promotes Renal Carcinoma Metastasis.
Rodrigues P; Patel SA; Harewood L; Olan I; Vojtasova E; Syafruddin SE; Zaini MN; Richardson EK; Burge J; Warren AY; Stewart GD; Saeb-Parsy K; Samarajiwa SA; Vanharanta S
Cancer Discov; 2018 Jul; 8(7):850-865. PubMed ID: 29875134
[TBL] [Abstract][Full Text] [Related]
2.
Yao X; Tan J; Lim KJ; Koh J; Ooi WF; Li Z; Huang D; Xing M; Chan YS; Qu JZ; Tay ST; Wijaya G; Lam YN; Hong JH; Lee-Lim AP; Guan P; Ng MSW; He CZ; Lin JS; Nandi T; Qamra A; Xu C; Myint SS; Davies JOJ; Goh JY; Loh G; Tan BC; Rozen SG; Yu Q; Tan IBH; Cheng CWS; Li S; Chang KTE; Tan PH; Silver DL; Lezhava A; Steger G; Hughes JR; Teh BT; Tan P
Cancer Discov; 2017 Nov; 7(11):1284-1305. PubMed ID: 28893800
[TBL] [Abstract][Full Text] [Related]
3. A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in renal carcinoma.
Syafruddin SE; Rodrigues P; Vojtasova E; Patel SA; Zaini MN; Burge J; Warren AY; Stewart GD; Eisen T; Bihary D; Samarajiwa SA; Vanharanta S
Nat Commun; 2019 Mar; 10(1):1152. PubMed ID: 30858363
[TBL] [Abstract][Full Text] [Related]
4. Downregulated METTL14 accumulates BPTF that reinforces super-enhancers and distal lung metastasis via glycolytic reprogramming in renal cell carcinoma.
Zhang C; Chen L; Liu Y; Huang J; Liu A; Xu Y; Shen Y; He H; Xu D
Theranostics; 2021; 11(8):3676-3693. PubMed ID: 33664855
[No Abstract] [Full Text] [Related]
5. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
[TBL] [Abstract][Full Text] [Related]
6. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
[TBL] [Abstract][Full Text] [Related]
7. Ghrelin promotes renal cell carcinoma metastasis via Snail activation and is associated with poor prognosis.
Lin TC; Liu YP; Chan YC; Su CY; Lin YF; Hsu SL; Yang CS; Hsiao M
J Pathol; 2015 Sep; 237(1):50-61. PubMed ID: 25925728
[TBL] [Abstract][Full Text] [Related]
8. The renal lineage factor PAX8 controls oncogenic signalling in kidney cancer.
Patel SA; Hirosue S; Rodrigues P; Vojtasova E; Richardson EK; Ge J; Syafruddin SE; Speed A; Papachristou EK; Baker D; Clarke D; Purvis S; Wesolowski L; Dyas A; Castillon L; Caraffini V; Bihary D; Yong C; Harrison DJ; Stewart GD; Machiela MJ; Purdue MP; Chanock SJ; Warren AY; Samarajiwa SA; Carroll JS; Vanharanta S
Nature; 2022 Jun; 606(7916):999-1006. PubMed ID: 35676472
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of RICTOR gene transcription by the proinflammatory cytokines through NF-κB pathway contributes to the metastasis of renal cell carcinoma.
Sun B; Chen L; Fu H; Guo L; Guo H; Zhang N
Tumour Biol; 2016 Apr; 37(4):4457-66. PubMed ID: 26500094
[TBL] [Abstract][Full Text] [Related]
10. LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells.
Liu H; Zheng H; Duan Z; Hu D; Li M; Liu S; Li Z; Deng X; Wang Z; Tang M; Shi Y; Yi W; Cao Y
Mol Cancer; 2009 Oct; 8():92. PubMed ID: 19860880
[TBL] [Abstract][Full Text] [Related]
11. RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway.
Yang XC; Wang X; Luo L; Dong DH; Yu QC; Wang XS; Zhao K
Eur Rev Med Pharmacol Sci; 2013 Jun; 17(12):1669-80. PubMed ID: 23832737
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis.
Li L; Ugalde AP; Scheele CLGJ; Dieter SM; Nagel R; Ma J; Pataskar A; Korkmaz G; Elkon R; Chien MP; You L; Su PR; Bleijerveld OB; Altelaar M; Momchev L; Manber Z; Han R; van Breugel PC; Lopes R; Ten Dijke P; van Rheenen J; Agami R
Genome Biol; 2021 Jan; 22(1):54. PubMed ID: 33514403
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA LINC01578 drives colon cancer metastasis through a positive feedback loop with the NF-κB/YY1 axis.
Liu J; Zhan Y; Wang J; Wang J; Guo J; Kong D
Mol Oncol; 2020 Dec; 14(12):3211-3233. PubMed ID: 33040438
[TBL] [Abstract][Full Text] [Related]
14. BHLHE40 confers a pro-survival and pro-metastatic phenotype to breast cancer cells by modulating HBEGF secretion.
Sethuraman A; Brown M; Krutilina R; Wu ZH; Seagroves TN; Pfeffer LM; Fan M
Breast Cancer Res; 2018 Oct; 20(1):117. PubMed ID: 30285805
[TBL] [Abstract][Full Text] [Related]
15. NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer.
Kanda K; Hu HM; Zhang L; Grandchamps J; Boxer LM
J Biol Chem; 2000 Oct; 275(41):32338-46. PubMed ID: 10931834
[TBL] [Abstract][Full Text] [Related]
16. Melatonin inhibits MMP-9 transactivation and renal cell carcinoma metastasis by suppressing Akt-MAPKs pathway and NF-κB DNA-binding activity.
Lin YW; Lee LM; Lee WJ; Chu CY; Tan P; Yang YC; Chen WY; Yang SF; Hsiao M; Chien MH
J Pineal Res; 2016 Apr; 60(3):277-90. PubMed ID: 26732239
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic remodelling shapes inflammatory renal cancer and neutrophil-dependent metastasis.
Nishida J; Momoi Y; Miyakuni K; Tamura Y; Takahashi K; Koinuma D; Miyazono K; Ehata S
Nat Cell Biol; 2020 Apr; 22(4):465-475. PubMed ID: 32203421
[TBL] [Abstract][Full Text] [Related]
18. [Transcription factors NF-kB, HIF-1, HIF-2, growth factor VEGF, VEGFR2 and carboanhydrase IX mRNA and protein level in the development of kidney cancer metastasis].
Spirina LV; Usynin YA; Yurmazov ZA; Slonimskaya EM; Kolegova ES; Kondakova IV
Mol Biol (Mosk); 2017; 51(2):372-377. PubMed ID: 28537244
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer.
Vanharanta S; Shu W; Brenet F; Hakimi AA; Heguy A; Viale A; Reuter VE; Hsieh JJ; Scandura JM; Massagué J
Nat Med; 2013 Jan; 19(1):50-6. PubMed ID: 23223005
[TBL] [Abstract][Full Text] [Related]
20. In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype.
Bossi D; Cicalese A; Dellino GI; Luzi L; Riva L; D'Alesio C; Diaferia GR; Carugo A; Cavallaro E; Piccioni R; Barberis M; Mazzarol G; Testori A; Punzi S; Pallavicini I; Tosti G; Giacó L; Melloni G; Heffernan TP; Natoli G; Draetta GF; Minucci S; Pelicci P; Lanfrancone L
Cancer Discov; 2016 Jun; 6(6):650-63. PubMed ID: 27179036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
